Ischemic Heart Disease Clinical Trial
Official title:
CSP #517 - Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass
Ischemic heart disease is one of the most frequent diagnoses in the VA system. Moreover, 5,819 coronary artery bypass graft (CABG-only) procedures were performed in the VA in Fiscal Year (FY) 1999. Throughout VA and non-VA cardiac surgery programs nationwide, myocardial revascularization is now being performed using two surgical techniques. One technique is performed with cardiopulmonary bypass (CPB) usually with cardioplegic arrest ("on-pump") and the other without CPB on a beating heart ("off-pump"). The overall purpose of this proposed randomized, controlled, clinical trial is to rigorously evaluate the impact of using an on-pump versus off-pump surgical technique for coronary artery bypass graft (CABG-only) procedures (performed with a traditional median sternotomy incision) upon patient clinical outcomes and resource utilization.
Primary Hypotheses: The study has two primary hypotheses to evaluate the impact of using an
off-pump versus an on-pump surgical technique for CABG procedures. One is a short term
objective to assess the immediate impact of the two surgical techniques while the second
assesses the long-term impact of the two techniques: 1) Short-Term Null Hypothesis: For
patients having CABG-only procedures performed, there will be no difference in the
short-term composite clinical outcome (30 day death or major morbidity) between patients
randomized to the on-pump and off-pump procedures, 2) Long-Term Null Hypothesis: For
patients undergoing CABG-only procedures, there will be no difference in long-term clinical
outcome as measured by one year mortality and/or acute myocardial infarction prior to one
year and/or a subsequent revascularization procedure within one year between patients
randomized to the on-pump and off-pump procedures.
Secondary Hypotheses: Major secondary objectives are to determine if there are differences
in patients undergoing CABG-only procedures using the on-pump and off-pump techniques for 1)
long-term completeness of revascularization, 2) one year graft patency and stenosis rates as
determined by angiography at one year, and 3) short-term completeness of revascularization.
Other secondary objectives are to evaluate the two surgical techniques on 1) changes in
neuropsychological function, 2) traditional clinical outcomes, 3) general and disease
specific quality of life, and 4) use of system resources.
Intervention: Patients requiring an elective or urgent CABG-only (no other procedures to be
done) surgical procedure will be randomized to either the off-pump procedure or to the
on-pump procedure.
Primary Outcomes: The short-term primary outcome measure is a composite measure of death,
repeat cardiac surgery, new technical support, cardiac arrest, coma, prolonged stroke and/or
renal failure requiring dialyses occurring within 30 days of surgery or prior to discharge,
whichever is latest. The long-term primary outcome measure is a composite of death, acute
myocardial infarction, and/or subsequent revascularization procedure prior to one year
post-surgery.
Study Abstract: Ischemic heart disease is one of the most frequent diagnoses in the VA
system. Moreover, 5,819 coronary artery bypass graft (CABG-only) procedures were performed
in the VA in FY 1999. Throughout VA and non-VA cardiac surgery programs nationwide,
myocardial revascularization is now being performed using two surgical techniques. One
technique is performed with cardiopulmonary bypass (CPB) usually with cardioplegic arrest
("on-pump") and the other without CPB on a beating heart ("off-pump"). The overall purpose
of this proposed randomized, controlled, clinical trial is to rigorously evaluate the impact
of using an on-pump versus off-pump surgical technique for coronary artery bypass graft
(CABG-only) procedures (performed with a traditional median sternotomy incision) upon
patient clinical outcomes and resource utilization.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
| Active, not recruiting |
NCT04562805 -
Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
|
N/A | |
| Recruiting |
NCT05292079 -
CAPTURER PMCF Study ( rEPIC04D )
|
||
| Recruiting |
NCT05292092 -
Essential Pro PMCF Study ( rEPIC04E )
|
||
| Recruiting |
NCT05292014 -
ANGIOLITE PMCF Study ( rEPIC04F )
|
||
| Recruiting |
NCT05292118 -
Navitian PMCF Study ( rEPIC04C )
|
||
| Completed |
NCT05292105 -
NC Xperience PMCF Study( rEPIC04B)
|
||
| Completed |
NCT03076801 -
Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease?
|
N/A | |
| Not yet recruiting |
NCT04153383 -
Milrinone on Cardiac Performance During Off-pump Coronary Artery Bypass Surgery
|
||
| Recruiting |
NCT02729064 -
Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose
|
Phase 1 | |
| Recruiting |
NCT02982434 -
The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation
|
Phase 2 | |
| Completed |
NCT02468401 -
Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions
|
N/A | |
| Completed |
NCT02759406 -
Evaluation of the Palmaz Mach-5 Grooved Bare Metal Coronary Stent System Versus the Palmaz Bare Metal Coronary Stent System in Patients With Symptomatic Ischemic Heart Disease: A Safety and Performance Study
|
N/A | |
| Recruiting |
NCT01681381 -
Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization
|
N/A | |
| Completed |
NCT01699802 -
Influence of Inhaled Anaesthetics on Rebreathing of Carbon Dioxide When Using an Anaesthesia Gas Reflector (AnaConDa)
|
N/A | |
| Completed |
NCT01604213 -
Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease
|
Phase 4 | |
| Completed |
NCT01334268 -
RESOLUTE China RCT
|
N/A | |
| Completed |
NCT01724567 -
Copenhagen Study of Obese Patients With Ischemic Heart Disease Undergoing Low Energy Diet or Interval Training
|
N/A | |
| Completed |
NCT02159235 -
Heavy Metals, Angiogenesis Factors and Osteopontin in Coronary Artery Disease (CAD)
|
N/A |